Menu
April 27, 2021

April 16th VAERS Data Show Reports of Blood Clotting

Overview

VAERS data released on April 16th showed 795 reports related to blood clotting disorders with 400 attributed to Pfizer, 337 to Moderna and 56 to Johnson & Johnson between Dec. 14, 2020 and April 8, 2021.

This article originally appeared on 4/16 on Children Health Defense National, written by Megan Redshaw


Data released on April 16th by the Centers for Disease Control and Prevention (CDC) on the number of injuries and deaths reported to the Vaccine Adverse Event Reporting System (VAERS) following COVID vaccines revealed reports of blood clots and other related blood disorders associated with all three vaccines approved for Emergency Use Authorization in the U.S. — PfizerModerna and Johnson & Johnson (J&J). So far, only the J&J vaccine has been paused because of blood clot concerns.

VAERS is the primary mechanism for reporting adverse vaccine reactions in the U.S. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.

Every Friday, VAERS makes public all vaccine injury reports received through a specified date, usually about a week prior to the release date. Today’s data show that between Dec. 14, 2020 and April 8, a total of 68,347 total adverse events were reported to VAERS, including 2,602 deaths — an increase of 260 over the previous week — and 8,285 serious injuries, up 314 since last week.

Of the 2,602 deaths reported as of April 8, 27% occurred within 48 hours of vaccination, 19% occurred within 24 hours and 41% occurred in people who became ill within 48 hours of being vaccinated.

In the U.S., 174.9 million COVID vaccine doses had been administered as of April 8. This includes 79.6 million doses of Moderna’s vaccine, 90.3 million doses of Pfizer and 4.9 million doses of the J&J COVID vaccine.

This week’s VAERS data show:

This article originally appeared on national site of Children Health Defense, written by Megan Redshaw